Influence of department volume on survival for ovarian cancer: Results from a prospective quality assurance program of the austrian association for gynecologic oncology

International Journal of Gynecological Cancer

Volumn 19, Issue 1, 2009, Pages 94-102

  Marth, Christian ^a   Hiebl, Sonja ^b   Oberaigner, Willi ^c   Winter, Raimund ^d   Leodolter, Sepp ^e   Sevelda, Paul ^f  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Hospital Barmherzige Schwestern Linz   (Austria)

^c Tyrolean State Hospitals Ltd   (Austria)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^f Hietzing Hospital   (Austria)

Author keywords

Department volume; Minimum case load; Ovarian cancer; Survival rate

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; DEMOGRAPHY; FEMALE; HEALTH CARE QUALITY; HEALTH STATUS; HOSPITAL DEPARTMENT; HUMAN; HYSTERECTOMY; INTESTINE RESECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CANCER; OVERALL SURVIVAL; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY CONTROL; QUESTIONNAIRE; SALPINGOOOPHORECTOMY; TREATMENT OUTCOME; AUSTRIA; GYNECOLOGY; MORTALITY; OVARY TUMOR; STATISTICS;

AUSTRIA; FEMALE; GYNECOLOGY; HUMANS; OVARIAN NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE;

EID: 65649118162     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e31819915cb     Document Type: Article

References (26)

1. Olaitan A, Weeks J, Mocroft A, et al. The surgical management of women with ovarian cancer in the south west of England. Br J Cancer. 2001;85(12):1824-1830.
2. Bailey J, Murdoch J, Anderson R, et al. Stage III and IV ovarian cancer in the South West of England: five-year outcome analysis for cases treated in 1998. Int J Gynecol Cancer. 2006;16(1):25-29.
3. Kehoe S, Powell J, Wilson S, et al. The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma. Br J Cancer. 1994;70(5):1014-1017.
4. Junor EJ, Hole DJ, McNulty L, et al. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol. 1999;106(11):1130-1136.
5. Oksefjell H, Sandstad B, Trope C. Improved survival for stage IIIC ovarian cancer patients treated at the Norwegian Radium Hospital between 1984 and 2001. Eur J Gynaecol Oncol. 2007;28(4):256-262.
6. Paulsen T, Kjaerheim K, Kaern J, et al. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer. 2006;16(suppl 1):11-17.
7. Elit L, Bondy SJ, Paszat L, et al. Outcomes in surgery for ovarian cancer. Gynecol Oncol. 2002;87(3):260-267.
8. Ioka A, Tsukuma H, Ajiki W, et al. Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer. Cancer Sci. 2004;95(3):233-237.
9. Kumpulainen S, Grenman S, Kyyronen P, et al. Evidence of benefit from centralised treatment of ovarian cancer: a nationwide population-based survival analysis in Finland. Int J Cancer. 2002; 102(5):541-544.
10. Chan JK, Kapp DS, Shin JY, et al. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007;109(6):1342-1350.
11. Oberaigner W, Stuhlinger W. Influence of department volume on cancer survival for gynaecological cancersVa population-based study in Tyrol, Austria. Gynecol Oncol. 2006;103(2):527-534.
12. Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000;18(11):2327-2340.
13. Obermair A, Oberaigner W, Marth C. Wie gut ist die Behandlung des Ovarialkarzinoms in Österreich? Frauenarzt. 2003;7:732-736.
14. Winter WE, 3rd, Maxwell GL, Tian C, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2007;25(24):3621-3627.
15. Tingulstad S, Skjeldestad FE, Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol. 2003;102(3):499-505.
16. Wimberger P, Lehmann N, Kimmig R, et al. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol. 2007; 106:69-74.
17. Eisenkop SM, Spirtos NM, Friedman RL, et al. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol. 2003;90(2):390-396.
18. Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20(5): 1248-1259.
19. Chi DS, Eisenhauer EL, Lang J, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103(2):559-564.
20. von Georgi R, Franke FE, Munstedt K. Influence of surgery and postoperative therapy and tumor characteristics on patient prognosis in advanced ovarian carcinomas. Eur J Obstet Gynecol Reprod Biol. 2003;111(2):189-196.
21. Aletti GD, Gostout BS, Podratz KC, et al. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol Oncol. 2006;100(1):33-37.
22. Burghardt E, Pickel H, Lahousen M, et al. Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol. 1986; 155(2):315-319.
23. Scarabelli C, Gallo A, Zarrelli A, et al. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol. 1995;56(3): 328-337.
24. Chan JK, Urban R, Hu JM, et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13,918 patients. Br J Cancer. 2007;96(12):1817-1822.
25. Spirtos NM, Gross GM, Freddo JL, et al. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol Oncol. 1995;56(3):345-352.
26. Panici PB, Maggioni A, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97(8):560-566.